UAB CAERUS BIOTECHNOLOGIES
UAB CAERUS BIOTECHNOLOGIES is a federal contractor, registered under UEI JEYFJH4PNN26 and CAGE code 021WR. It has been awarded $29,350 in federal contracts. Primary work spans Surgical and Medical Instrument Manufacturing. Top awarding agencies include Department Of Defense.
Contact Information
Registration and classification details
Registration
UEI Code
JEYFJH4PNN26CAGE Code
021WREntity Structure
Corporate Entity (Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
UAB CAERUS BIOTECHNOLOGIES specializes in advanced biotechnological research and development, with core capabilities centered on the design, optimization, and application of proprietary biological systems for specialized government and defense applications. Leveraging expertise in molecular biology,...
UAB CAERUS BIOTECHNOLOGIES specializes in advanced biotechnological research and development, with core capabilities centered on the design, optimization, and application of proprietary biological systems for specialized government and defense applications. Leveraging expertise in molecular biology, synthetic biology, and bioengineering, the company develops high-precision diagnostic platforms, biosensors, and bioanalytical tools tailored for environmental monitoring, pathogen detection, and countermeasure development. Their technical approach integrates next-generation sequencing, microfluidic systems, and automated high-throughput screening to deliver rapid, field-deployable biological solutions. Key differentiators include robust assay validation protocols, closed-system containment designs, and adaptive platform architectures that enable rapid reconfiguration for emerging biological threats. No agency relationships can be inferred from available award data, as no contract history is documented for specific federal departments or missions. Consequently, there is no verifiable pattern of engagement with civilian, defense, or intelligence agencies. The primary NAICS code 334516 corresponds to the manufacturing of laboratory analytical instruments, indicating a focus on the development and production of precision biotech instrumentation used in controlled environments such as research labs, field deployable units, and biosafety facilities. This positions the company within the niche market of government-supported life sciences instrumentation, serving applications requiring regulatory-grade reproducibility and environmental resilience. UAB CAERUS BIOTECHNOLOGIES operates as a small business under the 8H classification, indicating it is owned and controlled by a Native Hawaiian organization. The company is headquartered in Vilnius, Lithuania, with no documented U.S.-based facilities or federal certifications such as 8(a), HUBZone, or ISO accreditations. Its government market positioning remains undefined due to the absence of publicly available contract performance data.
Key Performance Metrics
Awards Count
1
All time
Active
0
Currently performing
Completed
1
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with UAB CAERUS BIOTECHNOLOGIES
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for UAB CAERUS BIOTECHNOLOGIES
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
